Pancreatic main-duct involvement in branch-duct IPMNs: An underestimated risk

Annals of Surgery

Volumn 260, Issue 5, 2014, Pages 848-856

  Fritz, Stefan ^a   Klauss, Miriam ^b   Bergmann, Frank ^a   Strobel, Oliver ^a   Schneider, Lutz ^a   Werner, Jens ^a   Hackert, Thilo ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Diagnostic and Interventional Radiology ^*  (Germany)

Author keywords

Cancer; Intraductal papillarymucinous neoplasm; Main duct involvement; Mixed type; Pancreas

Indexed keywords

BILIRUBIN; CA 19-9 ANTIGEN; BIOLOGICAL MARKER;

ABDOMINAL ABSCESS; ADENOCARCINOMA; ADULT; AGED; ANASTOMOSIS LEAKAGE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; COHORT ANALYSIS; COLLOID CARCINOMA; CONFERENCE PAPER; CYSTIC NEOPLASM; DELAYED GASTRIC EMPTYING; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MORTALITY; PANCREAS FISTULA; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATIC BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PANCREATIC MAIN DUCT INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PANCREATICODUODENECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH FUNCTION DISORDER; TUMOR GROWTH; VERY ELDERLY; ADENOCARCINOMA, MUCINOUS; BLOOD; CANCER GRADING; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DIAGNOSTIC IMAGING; MIDDLE AGED; PANCREAS DUCT; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PANCREATIC DUCTS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926112900     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000980     Document Type: Conference Paper

References (47)

1. Hruben RH, Pitman MB, Klimstra DS. Intraductal neoplasms. In: Hruben RH, Pitman MB, Klimstra DS, eds. AFIP Atlas of Tumor Pathology, Series 4: Tumors of the Pancreas. Washington, DC: American Registry of Pathology; 2007:75-110.
2. Adsay NV, Fukushima N, Furukawa T. Intraductal Neoplasms of the Pancreas in WHO Classification of Tumor of the Digestive System. Lyon, France: International Agency for Research on Cancer; 2010.
3. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-197.
4. Werner J, Fritz S, Buchler MW. Intraductal papillary mucinous neoplasms of the pancreas-a surgical disease. Nat Rev Gastroenterol Hepatol. 2012;9: 253-259.
5. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010;139:708-713, e1-e2.
6. Farrell JJ, Fernandez-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144:1303-1315.
7. Salvia R, Crippa S, Partelli S, et al. Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg. 2010;2:342-346.
8. Ferrone CR, Correa-Gallego C, Warshaw AL, et al. Current trends in pancreatic cystic neoplasms. Arch Surg. 2009;144:448-454.
9. Pitman MB, Lewandrowski K, Shen J, et al. Pancreatic cysts: Preoperative diagnosis and clinical management. Cancer Cytopathol. 2010;118:1-13.
10. Waters JA, Schmidt CM. Intraductal papillary mucinous neoplasm-when to resect? Adv Surg. 2008;42:87-108.
11. Fritz S, Warshaw AL, Thayer SP. Management of mucin-producing cystic neoplasms of the pancreas. Oncologist. 2009;14:125-136.
12. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: Observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79; quiz 309-310.
13. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102:1759-1764.
14. Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines formanagement of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6:815-819; quiz 719.
15. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms andmucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
16. Fritz S, Hackert T, Hinz U, et al. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg. 2011;98: 104-110.
17. Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol. 2011;9:87-93.
18. He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216:657-665; discussion 665-667.
19. Fritz S, Schirren M, Klauss M, et al. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2012;152:S74-S80.
20. Sturm EC, Roch AM, Shaffer KM, et al. Obesity increases malignant risk in patients with branch-duct intraductal papillary mucinous neoplasm. Surgery. 2013;154:803-808; discussion 808-809.
21. Correa-Gallego C, Ferrone CR, Thayer SP, et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 10(2-3):144-150.
22. Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: From the surgeon's presumption to the pathologist's reality. Surgery. 2012;152:S135-S142.
23. Arlix A, Bournet B, Otal P, et al. Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012;41:295-301.
24. Levy P, Jouannaud V, O'Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: Actuarial risk of malignancy. Clin Gastroenterol Hepatol. 2006;4:460-468.
25. Garcea G, Dennison AR. Branch-type intraductal papillary mucinous neoplasms: An update. Pancreatology. 2011;11:336-342.
26. Walsh RM, Vogt DP, Henderson JM, et al. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery. 2008;144:677-684; discussion 684-685.
27. Weinberg BM, Spiegel BM, Tomlinson JS, et al. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531-540.
28. Mann DV, Edwards R, Ho S, et al. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26:474-479.
29. Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: A Japanese multi-institutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas. 2004;28:241-246.
30. Crippa S, Fernandez-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: An analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010;8:213-219.
31. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654.
32. Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639-646; discussion 646.
33. Conlon KC. Intraductal papillary muci nous tumors of the pancreas. J Clin Oncol. 2005;23:4518-4523.
34. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247:571-579.
35. Shimizu Y, Yamaue H, Maguchi H, et al. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: Analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas. 2013;42: 883-888.
36. Ingkakul T, Warshaw AL, Fernandez-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: Sex differences between 3 geographic regions. Pancreas. 2011;40:779-780.
37. Sahora K, Mino-Kenudson M, Brugge W, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large singleinstitutional series. Ann Surg. 2013;258:466-475.
38. Correa-Gallego C, BrennanMF, Fong Y, et al. Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms-also not harmless. Ann Surg. 2014;259:e45.
39. Valsangkar NP, Morales-Oyarvide V, Thayer SP, et al. 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152:S4-12.
40. Hackert T, Hinz U, Fritz S, et al. Enucleation in pancreatic surgery: Indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg. 2011;396:1197-1203.
41. Fritz S, Klauss M, Bergmann F, et al. Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg. 2012;256:313-320.
42. Wong J, Weber J, Centeno BA, et al. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasmmeasuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg. 2013;17:78-84; discussion 84-85.
43. Karasaki H, Mizukami Y, Tokusashi Y, et al. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2011;40:588-594.
44. Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703-711.
45. Zlotta AR, Egawa S, Pushkar D, et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst. 2013;105:1050-1058.
46. Spinelli KS, Fromwiller TE, Daniel RA, et al. Cystic pancreatic neoplasms: Observe or operate. Ann Surg. 2004;239:651-657; discussion 657-659.
47. Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36-40.